Cancer Vaccines Market Size, Share, Industry, Forecast, and Outlook (2024-2031)

Comments ยท 99 Views

The cancer vaccines market growing at a CAGR of 18% during the forecast period (2024-2031).

Overview

The cancer vaccines market growing at a CAGR of 18% during the forecast period (2024-2031). 

Cancer can be treated with various drugs and vaccines, which are generally classified as either preventive or therapeutic. Preventive cancer vaccines are designed to protect against cancers caused by oncoviruses, such as those triggered by human papillomavirus (HPV), while therapeutic vaccines stimulate the body's adaptive immune system by targeting tumor antigens.

Cancer vaccines come in different forms, including antigen-based, dendritic cell, and anti-idiotype vaccines. There are also several specific types of vaccines, such as personalized cancer vaccines, anthrax vaccines, and others.

Request for free sample:https://www.datamintelligence.com/download-sample/cancer-vaccines-market

Market Growth Trends

Increasing clinical trials for cancer vaccines by the market players is expected to drive market growth.

Pancreatic Ductal Adenocarcinoma (PDAC) is a common form of pancreatic cancer for which no effective treatments currently exist. BioNTech, known for its mRNA vaccines, has released phase 1 clinical trial data for its PDAC vaccine. This mRNA vaccine delivers the genetic code for neoantigens—proteins produced by cancer cells—into the patient's cells, instructing them to produce these proteins.

This process helps stimulate the immune system to target and attack the tumor. Additionally, GSK plc is developing BLENREP (belantamab mafodotin), an antibody-drug conjugate (ADC) targeting B-cell maturation antigen, for the treatment of multiple myeloma, which is currently in Phase III trials.

Get your customized report @https://www.datamintelligence.com/customize/cancer-vaccines-market

Market is segmented

By Technology:  Dendritic Cells Vaccines, Anti-idiotype Vaccines, Antigen Vaccines, Whole Tumor Vaccines, DNA Vaccines

By Type:  Preventive Cancer Vaccines, Treatment Cancer Vaccines

By Disease Type:  Cervical Cancer, Prostate Cancer, Others

By Region:  North America, Latin America, Europe, Asia Pacific, Middle East, and Africa

Market Key Players

·         Ose-Immuno

·         Merck & Co. Inc.

·         IO Biotech

·         Medigene AG

·         Northwest Biotherapeutics

·         GlaxoSmithKline

·         Dendreon Pharmaceuticals LLC

·         Dynavax Technologies Corporation

·         Immunophotonics

·         Codagenix

Related Reports

Peptide Cancer Vaccine Market

Personalized Cancer Vaccines Market

Contact Us:

Company Name: DataM Intelligence

Email: info@datamintelligence.com

Contact Person: Sai. K

Phone: +1 877 441 4866

Website: https://www.datamintelligence.com

About DataM Intelligence:

DataM Intelligence 4Market Research is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. At DataM Intelligence, we leverage our top trademark trends, insights, and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across

Comments